BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 32382351)

  • 1. A Proposed Modified Staging System for Medullary Thyroid Cancer: A SEER Analysis With Multicenter Validation.
    Wang Z; Fan X; Zha X; Xu Y; Yin Z; Rixiati Y; Yu F
    Oncologist; 2024 Jan; 29(1):e59-e67. PubMed ID: 37311049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposal for uniformity in classification of lymph node stations in esophageal cancer.
    Schuring N; Matsuda S; Hagens ERC; Sano J; Mayanagi S; Kawakubo H; van Berge Henegouwen MI; Kitagawa Y; Gisbertz SS
    Dis Esophagus; 2021 Oct; 34(10):. PubMed ID: 33884407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consideration of Age Is Necessary for Increasing the Accuracy of the AJCC TNM Staging System of Pancreatic Neuroendocrine Tumors.
    Wang Z; Jiang W; Zheng L; Yan J; Dai J; Huang C; Zhang Q; Yin Z; Gong X; Zhang Y
    Front Oncol; 2019; 9():906. PubMed ID: 31608226
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of pretreatment
    Hou G; Zhao N; Li F; Jing H; Zheng R
    Front Oncol; 2023; 13():1145557. PubMed ID: 36994200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pretreatment contrast-enhanced computed tomography in esophageal neuroendocrine carcinoma: A multi-center follow-up study.
    Zhou Y; Hou P; Zha KJ; Wang F; Zhou K; He W; Gao JB
    World J Gastroenterol; 2020 Aug; 26(31):4680-4693. PubMed ID: 32884225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
    Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
    Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.
    Udagawa H; Ueno M
    Ann Transl Med; 2018 Feb; 6(4):76. PubMed ID: 29666799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification.
    Wang H; Chen Y; Pi G; Zhu Y; Yang S; Mei H; Lin Z; Zhang T
    Oncol Lett; 2020 Jun; 19(6):4122-4132. PubMed ID: 32382351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
    Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
    Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
    Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
    BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
    Jiang W; Zhao B; Li Y; Qi D; Wang D
    BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer.
    Hu K; Kang N; Liu Y; Guo D; Jing W; Lu J; Tan T; Lv C; Deng Y; Long J; Wang R; Yu J
    Cancer Sci; 2019 Feb; 110(2):717-725. PubMed ID: 30467921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma.
    Deng HY; Li G; Luo J; Li XR; Alai G; Lin YD
    World J Surg; 2018 Aug; 42(8):2428-2436. PubMed ID: 29340724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
    Martin JA; Warner RR; Wisnivesky JP; Kim MK
    Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.